Legal & General Group PLC Alx Oncology Holdings Inc Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Legal & General Group PLC holds 28,926 shares of ALXO stock, worth $56,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,926

Previous 17,186 68.31%

Holding current value

$56,984

Previous $191,000 8.9%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.84 - $17.56 $68,561 - $206,154	11,740 Added 68.31%	28,926 $174,000
Q1 2024 May 14, 2024	BUY	$10.95 - $16.79 $163,122 - $250,120	14,897 Added 650.81%	17,186 $191,000
Q4 2023 Feb 15, 2024	BUY	$4.81 - $15.38 $3,290 - $10,519	684 Added 42.62%	2,289 $34,000
Q3 2023 Nov 14, 2023	SELL	$4.19 - $7.35 $2,413 - $4,233	-576 Reduced 26.41%	1,605 $7,000
Q2 2023 Aug 14, 2023	SELL	$4.37 - $9.56 $4,732 - $10,353	-1,083 Reduced 33.18%	2,181 $16,000
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $16,235 - $42,062	-3,592 Reduced 52.39%	3,264 $14,000
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $12,731 - $23,421	1,547 Added 29.14%	6,856 $65,000
Q2 2022 Aug 22, 2022	BUY	$5.89 - $19.46 $9,035 - $29,851	1,534 Added 40.64%	5,309 $43,000
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $709 - $2,455	33 Added 0.88%	3,775 $81,000
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $83,910 - $129,294	1,598 Added 74.53%	3,742 $276,000
Q2 2021 Aug 12, 2021	BUY	$52.2 - $75.23 $2,035 - $2,933	39 Added 1.85%	2,144 $117,000
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $46,878 - $65,409	746 Added 54.89%	2,105 $155,000
Q4 2020 Feb 12, 2021	BUY	$34.11 - $112.26 $9,857 - $32,443	289 Added 27.01%	1,359 $117,000
Q3 2020 Nov 13, 2020	BUY	$29.36 - $47.1 $31,415 - $50,397	1,070 New	1,070 $40,000

Others Institutions Holding ALXO

# of Institutions

122

Shares Held

40.7M

Call Options Held

518K

Put Options Held

142K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $80.3M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Alx Oncology Holdings Inc Transaction History